Skip to main content
Premium Trial:

Request an Annual Quote

Cellular Dynamics, Roche Update Alliance Covering Cardiotoxicity Platform

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Cellular Dynamics International today said that its agreement with Roche to substantiate CDI's platform for assessing the potential toxicity of drug candidates for heart disease has progressed to a standard supply agreement.

The two-year agreement, which took effect in March 2009, to substantiate CDI's iCell Cardiomyocytes as a predictive tool was completed early, and the platform will now be incorporated into Roche's drug development decision-making process, CDI said.

The agreement originally was to evaluate the iCell Cardiomyocytes tool against a well-characterized compound reference set in order to test the myocytes' ability to predict drug-induced, potentially life-threatening cardiac arrhythmias. Testing involved longitudinal genetic and molecular characterizations of the cardiomyocytes and comparing their performance across established and new testing platforms designed to detect possible cardiotoxic effects of new compounds early in their development cycle.

"We have developed iCell Cardiomyocytes as a cardiac cell model that truly reflects human biology," Robert Palay, chairman and CEO of CDI, said in a statement. "In addition, we have developed a manufacturing process that enables us to reliably deliver the cells in the quantity, quality, and purity that our customers require to successfully accomplish their drug discovery and toxicity testing research."

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.